InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Howe Jill Ann. Director active across 3 companies, notably PROGENITY, INC.. In total, 7 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €17k. History available since 3 November 2021. The latest transaction was disclosed on 26 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Howe Jill Ann is a declarant with 7 filings in total. In the sample of recent filings covering 2021-11-05 to 2024-11-26, buys total EUR 16990 and sells total EUR 0, with activity reported in Lineage Cell Therapeutics, Inc. and Biora Therapeutics, INC.; the modal transaction nature is Attribution.